On the call, they said the R&D costs were associated with some new product development and research trials. I think they said they've partnered with some universities for these trials.
There's also a note in the presentation that says there's new market opportunities for Reach to emerge with some major capability updates scheduled for Q1 2022. So it could be associated with that too.
- Forums
- ASX - By Stock
- Ann: FY21 Q4 Results Investor Presentation
On the call, they said the R&D costs were associated with some...
-
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LVT (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.474M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
LVT (ASX) Chart |
Day chart unavailable